Moreover, TAMs can inhibit the anti-tumor function of immune system by up-regulating the expression of immunosuppressive cytokines such as IL-10 and TGF-β, while down-regulating the expression of immune activating cytokines such as IL-12 [46, 47]. The gene discussed is TGFB1; the disease is neoplasm.